<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<div xmlns:jsp="http://java.sun.com/JSP/Page"
	xmlns:page="urn:jsptagdir:/WEB-INF/tags/form"
	xmlns:table="urn:jsptagdir:/WEB-INF/tags/form/fields"
	xmlns:util="urn:jsptagdir:/WEB-INF/tags/util" 
	xmlns:c="http://java.sun.com/jsp/jstl/core" version="2.0">
	<jsp:directive.page contentType="text/html;charset=UTF-8" />
	<jsp:output omit-xml-declaration="yes" />

	<div id="msgid"></div>
	<util:panel id="welcome" title="Welcome" openPane="true">
		<h1>Welcome to the GAME-ON GWAS look-up tool!</h1>
		<p>Here you can find association results between single nucleotide polymorphisms (SNPs) and breast cancer risk. You can search for a specific SNP, by gene or genetic region.</p><p>The association results are based on a meta-analysis of 12 breast cancer GWAS (Table 1), including a total of 16,003 cases and 41,335 controls. The studies included are ABCFS, BBCS, DFBBCS, MARIE, SASBAC, HEBCS, GC-HBOC, UK2, BPC3, BCFR and SardiNIA. Both estrogen receptor positive (ER+) and estrogen receptor negative (ER-) cases were included in this analysis. Subtype-specific results for ER- and ER+ breast cancer will be posted in the future. All studies were imputed to HapMap 2. Standard fixed-effects meta-analysis was used and the standard errors were adjusted by the inflation factors. If you have questions, please email us at <a href="mailto:gameon.gwas@gmail.com">gameon.gwas@gmail.com</a></p></util:panel>
	
	<util:panel title="List SNPs" id="ajax_id">
	<c:if test="${iTotalRecords>0}">		
		<input onclick="downloadButtonClick()" type="button" value="Download" style="float:right;"/>
	</c:if>
	<!-- 
	<table id="l_edu_dfci_cccb_gameon_domain_Snp_ajax">
    <thead><tr><th><a title="rs number" href="#">Marker Name</a></th><th><a title="rs number" href="#">Rs Number</a></th><th><a title="Genomic build" href="#">Build</a></th><th><a title="Chromosome" href="#">Chromosome</a></th><th><a title="Base pair position as listed in the Build" href="#">Coordinate</a></th><th><a title="Strand" href="#">Strand</a></th><th><a title="Number of studies included. Maximum is 4: BCAC (Includes 8 studies), BPC3, BCFR and Sardinia" href="#">Study</a></th><th><a title="Effect allele frequency in the UK GWAS" href="#">Eaf Uk Value</a></th><th><a title="Effect Allele" href="#">Effect Allele</a></th><th><a title="Ref Allele" href="#">Ref Allele</a></th><th><a title="Beta estimate for the effect on breast cancer risk using the Ref Allele as reference allele and Effect allele as effect allele (thus, a positive beta means that the effect allele increases breast cancer risk)" href="#">Beta value</a></th><th><a title="standard error" href="#">SE</a></th><th><a title="Odds ratio" href="#">OR Value</a></th><th><a title="Lower 95% confidence interval value" href="#">LCi</a></th><th><a title="Upper 95% confidence interval value" href="#">UCi</a></th><th><a title="P-value for the breast cancer association" href="#">P value</a></th><th></th></tr></thead>
			<tbody>
				<tr>
					<td colspan="5" class="dataTables_empty">Loading data from server</td>
				</tr>
			</tbody>
			<tfoot><tr><th><a title="rs number" href="#">Marker Name</a></th><th><a title="rs number" href="#">Rs Number</a></th><th><a title="Genomic build" href="#">Build</a></th><th><a title="Chromosome" href="#">Chromosome</a></th><th><a title="Base pair position as listed in the Build" href="#">Coordinate</a></th><th><a title="Strand" href="#">Strand</a></th><th><a title="Number of studies included. Maximum is 4: BCAC (Includes 8 studies), BPC3, BCFR and Sardinia" href="#">Study</a></th><th><a title="Effect allele frequency in the UK GWAS" href="#">Eaf Uk Value</a></th><th><a title="Effect Allele" href="#">Effect Allele</a></th><th><a title="Ref Allele" href="#">Ref Allele</a></th><th><a title="Beta estimate for the effect on breast cancer risk using the Ref Allele as reference allele and Effect allele as effect allele (thus, a positive beta means that the effect allele increases breast cancer risk)" href="#">Beta value</a></th><th><a title="standard error" href="#">SE</a></th><th><a title="Odds ratio" href="#">OR Value</a></th><th><a title="Lower 95% confidence interval value" href="#">LCi</a></th><th><a title="Upper 95% confidence interval value" href="#">UCi</a></th><th><a title="P-value for the breast cancer association" href="#">P value</a></th><th></th></tr></tfoot>
		</table>
	 -->
		
		<table:table data="${snps_empty}" id="l_edu_dfci_cccb_gameon_domain_Snp" path="/snps" show="false"  create="false" delete="false" update="false" showLegend="true" z="user-managed" >            
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_markerName" property="markerName" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_rsNumber" property="rsNumber" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_build" property="build" z="Oi+hzcAjhL9cfk+8R/wIXMSYvk4="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_chromosome" property="chromosome" z="GYxVmeIQFXjtzvJbbF8VN11Jk1M="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_coordinate" property="coordinate" z="2JAW8amMsbnnOlApb2HBICw9Ank="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_geneInfo" property="geneInfo" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_strand" property="strand" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_nStudy" property="NStudy" z=""/>            
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_eafUkValue" property="eafUkValue" z="OPh2BvVaZ/nfus4Ux2A/e3hHp4E="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_effectAllele" property="effectAllele" z="iUTIyadcbrozEqbuHmGOeTKQDZ8="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_refAllele" property="refAllele" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_betavalue" property="betavalue" z="PPIid6+M4Tdb0h+/LkzKiK1F0Hk="/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_seValue" property="seValue" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_orValue" property="orValue" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_lCiValue" property="LCiValue" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_uCiValue" property="UCiValue" z=""/>
            <table:column id="c_edu_dfci_cccb_gameon_domain_Snp_pValue" property="PValue" z=""/>
        </table:table>
	</util:panel>

	<util:panel id="reference" title="Reference" openPane="false">
		<p>If you use this resource in a publication, please cite http://gameon.dfci.harvard.edu and acknowledge DRIVE, funded by NCI Grant number U19 CA148065, as the coordinator for assembling the data and generating this website.</p>
		<h1>References for the meta-analysis</h1>
		<ul class="no-bullets-list">
		<li>
			Ghoussaini M et al (2012). Genome-wide association analysis
			identifies three new breast cancer susceptibility loci. Nat Genet
			44:312-8.
		</li><li>
			Michailidou K et al (2013). Large-scale genotyping
			identifies 41 new loci associated with breast cancer risk. Nat Genet
			45(4):353-61, 361e1-2 
		</li><li>
			Siddiq A et al (2012). A meta-analysis
			of genome-wide association studies of breast cancer identifies two
			novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet
			21:5373-5384.
		</li><li>
			Garcia-Closas M et al (2013). Genome-wide
			association studies identify four ER negative-specific breast cancer
			risk loci. Nat Genet 45(4):392-8, 398e1-2.
		</li>
		</ul>
		<span class="table-label">
		<span class="table-label-name">Table 1.</span> <span class="table-label-description">Breast Cancer GWAS studies included in the meta-analysis.</span>
		</span> 		
<table >
        <tr valign="bottom">
            <th>Study</th>
            <th>Country</th>

            <th>Case Ascertainment</th>

            <th>Control Ascertainment</th>

            <th>Genotyping platform</th>

            <th>Cases</th>

            <th>Controls</th>

            <th>Contact Principal Investigator</th>

            <th>Reference</th>
        </tr>

        <tr valign="bottom">
            <td>ABCFS/kConFab</td>

            <td>Australia</td>

            <td>Recruitment through cancer registries in Victoria and New
                South Wales</td>

            <td>Recruitment from the electoral rolls in Melbourne and Sydney
                matched to cases by age in-5 year categories</td>

            <td>Illumina 610k</td>

            <td>282</td>

            <td>285</td>

            <td>John Hopper</td>

            <td>1</td>
        </tr>

        <tr valign="bottom">
            <td>BBCS</td>

            <td>UK</td>

            <td>Recruitment through cancer registries and clinics in the UK,
                predominantly bilateral cases</td>

            <td>WTCCC2: 1958 Birth Cohort + UK National Blood Service</td>

            <td>Illumina 370k (cases) Illumina 1.2M (controls)</td>

            <td>1,609</td>

            <td>5,190</td>

            <td>Julian Peto</td>

            <td>2</td>
        </tr>

        <tr valign="bottom">
            <td>GC-HBOC</td>

            <td>Germany</td>

            <td>BRCA1/2 mutation negative cases from University Clinics in
                Cologne and Munich</td>

            <td>KORA (Cooperative Health Research in the Region
                Augsburg)</td>

            <td>Affymetrix 5.0k (cases) Affymetrix 6.0k (controls)</td>

            <td>634</td>

            <td>477</td>

            <td>AlfonsMeindl</td>

            <td>3</td>
        </tr>

        <tr valign="bottom">
            <td>MARIE</td>

            <td>Germany</td>

            <td>Random sample of cases from the MARIE study, but restricted
                to ductal and lobular carcinomas and oversampled for lobular
                (about 2:1)</td>

            <td>KORA (Cooperative Health Research in the Region
                Augsburg)</td>

            <td>Illumina 370k (cases) Illumina 550k (controls)</td>

            <td>708</td>

            <td>470</td>

            <td>Jenny Chang-Claude</td>

            <td>4</td>
        </tr>

        <tr valign="bottom">
            <td>HEBCS</td>

            <td>Finland</td>

            <td>Unselected cases plus additional familial cases from
                Helsinki University Central Hospital</td>

            <td>Population Controls from from the NordicDB, a Nordic pool
                and portal for genome-wide control data</td>

            <td>llumina 550k + 610k (cases) Illumina 370k (controls)</td>

            <td>810</td>

            <td>1,012</td>

            <td>HeliNevanlinna</td>

            <td>5, 6</td>
        </tr>

        <tr valign="bottom">
            <td>SASBAC</td>

            <td>Sweden</td>

            <td>Population- based case control study of postmenopausal
                women</td>

            <td>Population- based controls frequency matched by age to
                cases</td>

            <td>Illumina 317k+240k (cases) Illumina 550k (controls)</td>

            <td>790</td>

            <td>756</td>

            <td>Per Hall</td>

            <td>5</td>
        </tr>

        <tr valign="bottom">
            <td>UK2</td>

            <td>UK</td>

            <td>UK cancer genetics clinics + oncology clinics</td>

            <td>WTCCC2: 1958 Birth Cohort + UK National Blood Service</td>

            <td>Illumina 670k (cases) Illumina 1.2M (controls)</td>

            <td>3,628</td>

            <td>5,190</td>

            <td>Douglas Easton</td>

            <td>7</td>
        </tr>

        <tr valign="bottom">
            <td >DFBBS</td>

            <td>Netherlands</td>

            <td>BRCA1/2 mutation negative familial bilateral breast cancer
                patients selected from five clinical genetics centers; Erasmus
                University Medical Center/Daniel den Hoed, The Netherlands
                Cancer Institute, Leiden University Medical Center, University
                Medical Center Utrecht, and VU University Medical Center.</td>

            <td>Controls were from the Rotterdam study, and are 55 years or
                older at the time of inclusion. For this study females were
                selected and breast cancer cases were excluded.</td>

            <td>Illumina 610k (cases) Illumina 550k (controls)</td>

            <td>464</td>

            <td>3,255</td>

            <td>Quentin Waisfisz</td>

            <td>8</td>
        </tr>

        <tr valign="bottom">
            <td>BPC3</td>

            <td>US/Europe</td>

            <td>Estrogen Receptor negative cases from population based
                cohorts within the Breast and Prostate cancer cohort consortium
                (BPC3)</td>

            <td>Individually matched within cohorts in BPC3</td>

            <td>Illumina 660k+550K+317k</td>

            <td>2,188</td>

            <td>25,519</td>

            <td>Peter Kraft</td>

            <td>9</td>
        </tr>

        <tr>
            <td >BCFR</td>

            <td>US/Europe/Australia</td>

            <td>Population-based subjects were recruited from eight sites,
                some of which oversampled cases with a personal or family
                history. Eligible cases were non-Hispanic White women diagnosed
                with invasive breast cancer when 51 years or younger and not
                known to carry pathogenic mutations in BRCA1 or BRCA2.</td>

            <td>Eligible controls were non-hispanic white women aged 20-51
                years without a history of breast cancer, who were identified
                largely by random-digit dialing.</td>

            <td>Illumina 610k + Cyto 12)</td>

            <td>3,523</td>

            <td>2,702</td>

            <td>Habib Ahsan</td>

            <td>10</td>
        </tr>

        <tr valign="bottom">
            <td>SardiNIA</td>

            <td>Italy</td>

            <td></td>

            <td><br /></td>

            <td>Affymetrix 500k (cases) Affymetrix 6.0k (controls)</td>

            <td>1,367</td>

            <td>1,659</td>

            <td>Laura Crisponi</td>

            <td><br /></td>
        </tr>    
        <tr valign="bottom">
            <td>MARIE</td>

            <td>Germany</td>

            <td>Random sample of cases from the MARIE study, but restricted
                to ductal and lobular carcinomas and oversampled for lobular
                (about 2:1)</td>

            <td>KORA (Cooperative Health Research in the Region
                Augsburg)</td>

            <td>Illumina 370k (cases) Illumina 550k (controls)</td>

            <td>708</td>

            <td>470</td>

            <td>Jenny Chang-Claude</td>

            <td>4</td>
        </tr>

        <tr valign="bottom">
            <td>HEBCS</td>

            <td>Finland</td>

            <td>Unselected cases plus additional familial cases from
                Helsinki University Central Hospital</td>

            <td>Population Controls from from the NordicDB, a Nordic pool
                and portal for genome-wide control data</td>

            <td>llumina 550k + 610k (cases) Illumina 370k (controls)</td>

            <td>810</td>

            <td>1,012</td>

            <td>HeliNevanlinna</td>

            <td>5, 6</td>
        </tr>

        <tr valign="bottom">
            <td>SASBAC</td>

            <td>Sweden</td>

            <td>Population- based case control study of postmenopausal
                women</td>

            <td>Population- based controls frequency matched by age to
                cases</td>

            <td>Illumina 317k+240k (cases) Illumina 550k (controls)</td>

            <td>790</td>

            <td>756</td>

            <td>Per Hall</td>

            <td>5</td>
        </tr>

        <tr valign="bottom">
            <td>UK2</td>

            <td>UK</td>

            <td>UK cancer genetics clinics + oncology clinics</td>

            <td>WTCCC2: 1958 Birth Cohort + UK National Blood Service</td>

            <td>Illumina 670k (cases) Illumina 1.2M (controls)</td>

            <td>3,628</td>

            <td>5,190</td>

            <td>Douglas Easton</td>

            <td>7</td>
        </tr>

        <tr valign="bottom">
            <td>DFBBS</td>

            <td>Netherlands</td>

            <td>BRCA1/2 mutation negative familial bilateral breast cancer
                patients selected from five clinical genetics centers; Erasmus
                University Medical Center/Daniel den Hoed, The Netherlands
                Cancer Institute, Leiden University Medical Center, University
                Medical Center Utrecht, and VU University Medical Center.</td>

            <td>Controls were from the Rotterdam study, and are 55 years or
                older at the time of inclusion. For this study females were
                selected and breast cancer cases were excluded.</td>

            <td>Illumina 610k (cases) Illumina 550k (controls)</td>

            <td>464</td>

            <td>3,255</td>

            <td>Quentin Waisfisz</td>

            <td>8</td>
        </tr>

        <tr valign="bottom">
            <td>BPC3</td>

            <td>US/Europe</td>

            <td>Estrogen Receptor negative cases from population based
                cohorts within the Breast and Prostate cancer cohort consortium
                (BPC3)</td>

            <td>Individually matched within cohorts in BPC3</td>

            <td>Illumina 660k+550K+317k</td>

            <td>2,188</td>

            <td>25,519</td>

            <td>Peter Kraft</td>

            <td>9</td>
        </tr>

        <tr>
            <td>BCFR</td>

            <td>US/Europe/Australia</td>

            <td>Population-based subjects were recruited from eight sites,
                some of which oversampled cases with a personal or family
                history. Eligible cases were non-Hispanic White women diagnosed
                with invasive breast cancer when 51 years or younger and not
                known to carry pathogenic mutations in BRCA1 or BRCA2.</td>

            <td>Eligible controls were non-hispanic white women aged 20-51
                years without a history of breast cancer, who were identified
                largely by random-digit dialing.</td>

            <td>Illumina 610k + Cyto 12)</td>

            <td>3,523</td>

            <td>2,702</td>

            <td>Habib Ahsan</td>

            <td>10</td>
        </tr>

        <tr>
            <td>SardiNIA</td>
            <td>Italy</td>
            <td></td>
            <td><br /></td>
            <td>Affymetrix 500k (cases) Affymetrix 6.0k (controls)</td>
            <td>1,367</td>
            <td>1,659</td>
            <td>Laura Crisponi</td>
            <td></td>
        </tr>

    </table>
	</util:panel>
	<util:panel id="references" title="References" openPane="true">
		<h1>References</h1>
		<ol>
		<li>Dite,G.S. et al. J Natl Cancer Inst 95, 448-457 (2003). </li>
		<li>Fletcher,O. et al. J Natl Cancer Inst 98, 1014-1018 (2006).</li>
		<li>Frank,B. et al. Carcinogenesis 27, 606-609 (2006).</li>
		<li>Flesch-Janys,D. et al. Int J Cancer 123, 933-941 (2008).</li>
		<li>Li,J. et al. Breast Cancer Res Treat 126, 717-727 (2010).</li>
		<li>Leu,M. et al. Eur J Hum Genet 18, 1322-1326 (2010).</li>
		<li>Turnbull,C. et al. Nat Genet 42, 504-507 (2010).</li>
		<li>Hofman,A. et al. Eur J Epidemiol 24, 553-572 (2009).</li>
		<li>Siddiq, A, et al. Hum Mol Genet 15;21(24):5373-84 (2012)</li>
		<li>Ahsan et al, In press CEBP (2014)</li>
		</ol>
	</util:panel>
	<!-- button id="demo" onclick="doAjax()" title="Button">Get the time!</button-->
	<div id="terms_of_use_dialog" title="Terms of Use">
		<p>The sample size and precision of the data presented should preclude de-identification of any individual subject. However, in downloading these data, you undertake:<ul>
    <li>not to attempt to de-identify individual subjects.</li>
    <li>not to repost these data to a third party website.</li>
		</ul>
		</p>
		<!-- 
    <input type="button" id="agree_button" value="I agree with the terms above"/>
    <input type="button" id="cancel_button" value="Cancel" onclick="javascript: $('#terms_of_use_dialog').dialog().close();"/>
     -->  
	</div>
	
	<script type="text/javascript">
		function downloadButtonClick(){
			//$( "#terms_of_use_dialog" ).dialog( "open" );
			downloadPage();
		}
		function downloadPage(){
			//window.location.href="/gameon/snps?download=page&amp;"+sCurAjaxSource.substr(sCurAjaxSource.indexOf("?") + 1);			
			window.location.href="/gameon/snps?download=page&amp;"+getCurrentTableFilterQueryString();
		}
		
		function roundForDisplay(data){
			return isNaN(data) ? data : data.toPrecision(5);  //Rounds and keeps only 4 places after the decimal (data.toFixed(4) does not work for very small numbers that require sci.notation)			
		}
		
		$(document).ready(function(){		 
		
			var oTermsOfUseDialog = $("#terms_of_use_dialog").dialog({ 
				autoOpen: false,
				modal: true,
	      closeOnEscape: true,
				buttons: {
					"I agree with the terms above": function() { $(this).dialog("close"); downloadPage(); } ,
				  "I decline": function() { $(this).dialog("close"); } 
					}				
				});
			
			var oTable = $("#l_edu_dfci_cccb_gameon_domain_Snp").dataTable({
			        "bProcessing": true,
			        "oLanguage": {"sProcessing": "Processing... please wait, this may take a minute."},
			        "bServerSide": true,
			        "bFilter": false,
			        "bLengthChange": false,
			        "bSort": false,
			        "sDom": "&lt;&#39;top&#39;pi&gt;rt&lt;&#39;bottom&#39;fl&gt;&lt;&#39;clear&#39;&gt;",
			        "iDisplayStart": 0,
			        "iDisplayLength": ${iDisplayLength},
			        "iTotalRecords": ${iTotalRecords},
			        "iTotalDisplayRecords": ${iTotalRecords},	
			        "sAjaxSource": "/gameon/snps?find=json&amp;markerName=${param.markerName}&amp;build=${param.build}&amp;NStudy=${param.NStudy}&amp;chromosome=${param.chromosome}&amp;coordinateLower=${param.coordinateLower}&amp;coordinateUpper=${param.coordinateUpper}",
			        "fnServerData": function ( sSource, aoData, fnCallback ) 
			        {
								/* Add some extra data to the sender */							
								$.getJSON( sSource, aoData, function(json) { 											
										fnCallback(json);
											
								}).fail(function(jqxhr, textStatus, error ) {
								    console.log( "error:"+textStatus+" jqxhr:"+jqxhr.status);
								    if(jqxhr.status=="403"){
								    	window.location.href="/gameon/";
								    }
								    else{
								    	alert("An error occured while processing your requst ("+textStatus+":"+jqxhr.status+")");
								    	oTable.fnProcessingIndicator( false );
								    }
								  });
							},
			        "aoColumns": [
			                      { "mData": "markerName" },
			                      { "mData": "rsNumber" },
			                      { "mData": "build" },
			                      { "mData": "chromosome" },
			                      { "mData": "coordinate" },
			                      { "mData": "geneInfo" },
			                      { "mData": "strand" },
			                      { "mData": "nstudy" },
			                      { "mData": "eafUkValue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      },
			                      { "mData": "effectAllele" },
			                      { "mData": "refAllele" },
			                      { "mData": "betavalue", 
			                    	  "mRender": function ( data, type, full ) {
			                          return roundForDisplay(data);
			                      	}
			                      },
			                      { "mData": "seValue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      },
			                      { "mData": "orValue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      },
			                      { "mData": "lciValue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      },
			                      { "mData": "uciValue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      },
			                      { "mData": "pvalue", 
			                    	  "mRender": function ( data, type, full ) {
				                          return roundForDisplay(data);
				                      	}
			                      }
			                  ]
					});
		});		
	</script>
	<script>
		(function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
		(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
		m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  		})(window,document,'script','//www.google-analytics.com/analytics.js','ga');

		ga('create', 'UA-50681926-1', 'harvard.edu');
		ga('send', 'pageview');
	</script>
</div>
